
Response to Pemetrexed Chemotherapy in Lung Adenocarcinoma-Bronchioloalveolar Carcinoma Insensitive to Erlotinib
Keywords: Carboplatin; Cisplatin; Lymphadenopathy; Non–small-cell lung cancer; Paclitaxel; Single-agent therapy